Drugmaker Eli Lilly said Tuesday it is pausing its trial of a combination antibody treatment for coronavirus for safety reasons. Usually, clinical trials are paused because a volunteer has suffered a ...

Oct 14 (Reuters) - Eli Lilly & Co (LLY.N), opens new tab on Wednesday said other trials of its experimental coronavirus antibody therapy remain on track after a government-run study testing the ...

UnitedHealth Group is working with Eli Lilly on a clinical trial that will study at-home infusions of the drugmaker’s COVID-19 antibody treatment. Eli Lilly’s antibody drug, bamlanivimab, has received ...

Eli Lilly & Company (NYSE:LLY) ranks among the best fundamental stocks to buy right now. Eli Lilly & Company (NYSE:LLY) revealed plans on September 16 to build a $5 billion manufacturing facility in ...

SHANGHAI, Nov. 5, 2025 /PRNewswire/ -- Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi (2228.HK), a global leader in AI drug discovery, today announced a strategic ...

Feb 9 (Reuters) - Eli Lilly's (LLY.N), opens new tab combination antibody therapy to fight COVID-19 has been granted emergency use authorization by the U.S. Food and Drug Administration, Lilly said on ...